Ameriprise’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.52M Buy
754,240
+123,442
+20% +$929K ﹤0.01% 2501
2025
Q4
$4.52M Buy
630,798
+46,210
+8% +$365K ﹤0.01% 2508
2025
Q3
$6.24M Sell
584,588
-117,541
-17% -$1.15M ﹤0.01% 2265
2025
Q2
$6.8M Sell
702,129
-1,466
-0.2% -$15.1K ﹤0.01% 2111
2025
Q1
$10.5M Sell
703,595
-33,748
-5% -$519K ﹤0.01% 1731
2024
Q4
$11M Sell
737,343
-137,190
-16% -$2.24M ﹤0.01% 1722
2024
Q3
$16.7M Sell
874,533
-48,226
-5% -$1,000K ﹤0.01% 1435
2024
Q2
$19.1M Sell
922,759
-34,069
-4% -$677K 0.01% 1309
2024
Q1
$18M Buy
956,828
+26,283
+3% +$451K 0.01% 1373
2023
Q4
$13.4M Buy
930,545
+704,996
+313% +$9.59M ﹤0.01% 1537
2023
Q3
$3.91M Buy
225,549
+71,684
+47% +$1.49M ﹤0.01% 2469
2023
Q2
$3.26M Sell
153,865
-35,675
-19% -$775K ﹤0.01% 2624
2023
Q1
$4.46M Buy
189,540
+5,082
+3% +$136K ﹤0.01% 2401
2022
Q4
$5.15M Sell
184,458
-120,509
-40% -$3.08M ﹤0.01% 2273
2022
Q3
$7.14M Sell
304,967
-329,587
-52% -$9.95M ﹤0.01% 1959
2022
Q2
$21.4M Sell
634,554
-48,535
-7% -$1.7M 0.01% 1169
2022
Q1
$23.9M Buy
683,089
+53,577
+9% +$1.83M 0.01% 1217
2021
Q4
$19.2M Buy
629,512
+41,479
+7% +$1.35M 0.01% 1442
2021
Q3
$19.3M Buy
588,033
+266,657
+83% +$8.53M 0.01% 1292
2021
Q2
$9.72M Buy
+321,376
New +$10.6M ﹤0.01% 1962

Other funds holding OGN

Ameriprise's OGN Position: Q1 2026 in Review

Ameriprise increased its Organon & Co (OGN) stake by 20% in Q1 2026, buying an estimated $929K and bringing the position to 754,240 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

Ameriprise first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $23.9M in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Ameriprise held 754,240 shares of Organon & Co worth $4.52M as of Q1 2026.
  • Ameriprise bought 123,442 Organon & Co shares in Q1 2026, an estimated $929K.
  • Organon & Co made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2501 holding.
  • Ameriprise first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Ameriprise's Organon & Co position peaked at $23.9M in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.